Article
Biallelic cGMP-dependent type II protein kinase gene (PRKG2) variants cause a novel acromesomelic dysplasia.
Journal of medical genetics - 1 Jan 2022
Díaz-González Francisca, Wadhwa Saruchi, Rodriguez-Zabala Maria, Kumar Somesh, Aza-Carmona Miriam, Sentchordi-Montané Lucia, Alonso Milagros, Ahmad Istaq, Zahra Sana, Kumar Deepak, Kushwah Neetu, Shamim Uzma, Sait Haseena, Kapoor Seema, Roldán Belen, Nishimura Gen, Offiah Amaka C, Faruq Mohammed, Heath Karen E
Abstract excerpt
BACKGROUND: C-type natriuretic peptide (CNP), its endogenous receptor, natriuretic peptide receptor-B (NPR-B), as well as its downstream mediator, cyclic guanosine monophosphate (cGMP) dependent protein kinase II (cGKII), have been shown to play a pivotal role in chondrogenic differentiation and endochondral bone growth. In humans, biallelic variants in NPR2, encoding NPR-B, cause acromesomelic dysplasia, type...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
